SG Americas Securities’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

SG Americas Securities’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-10,950	Closed	-$821K	–	3242
2015 Q3	$821K	Sell	10,950 -18,756	-63%	-$1.4M	﹤0.01%	921
2015 Q2	$2.24M	Buy	29,706 +24,921	+521%	+$1.34M	0.01%	671
2015 Q1	$240K	Buy	4,785 +1,448	+43%	+$60.8K	﹤0.01%	1793
2014 Q4	$116K	Sell	3,337 -2,042	-38%	-$71.3K	﹤0.01%	2822
2014 Q3	$176K	Buy	+5,379	New	+$189K	﹤0.01%	2048
2013 Q4	–	Sell	-2,849	Closed	-$130K	–	3324
2013 Q3	$130K	Buy	+2,849	New	+$85.2K	﹤0.01%	2492

SG Americas Securities's KYTH Position: Q4 2015 in Review

SG Americas Securities sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 10,950 shares — an estimated $821K sold.

SG Americas Securities first reported a position in KYTH in Q3 2013 and held it in 6 quarters. The position peaked at $2.24M in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

SG Americas Securities reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
SG Americas Securities sold 10,950 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $821K.
SG Americas Securities first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 6 quarters.
SG Americas Securities's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.24M in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on SG Americas Securities's 13F filing for Q4 2015, filed 12 Feb 2016.